Hims & Hers Health, Inc.HIMSEarnings & Financial Report
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
HIMS Q4 2025 Key Financial Metrics
Revenue
$617.8M
Gross Profit
$444.4M
Operating Profit
$9.2M
Net Profit
$20.6M
Gross Margin
71.9%
Operating Margin
1.5%
Net Margin
3.3%
YoY Growth
28.4%
EPS
$0.08
Financial Flow
Hims & Hers Health, Inc. Q4 2025 Financial Summary
Hims & Hers Health, Inc. reported revenue of $617.8M (up 28.4% YoY) for Q4 2025, with a net profit of $20.6M (down 20.8% YoY) (3.3% margin). Cost of goods sold was $173.4M, operating expenses totaled $435.2M.
Key Financial Metrics
| Total Revenue | $617.8M |
|---|---|
| Net Profit | $20.6M |
| Gross Margin | 71.9% |
| Operating Margin | 1.5% |
| Report Period | Q4 2025 |
Hims & Hers Health, Inc. Annual Revenue by Year
Hims & Hers Health, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.3B). Click any linked year to see what changed vs the prior annual report.
Hims & Hers Health, Inc. Quarterly Revenue & Net Profit History
Hims & Hers Health, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $617.8M | +28.4% | $20.6M | 3.3% |
| Q3 2025 | $599.0M | +49.2% | $15.8M | 2.6% |
| Q2 2025 | $544.8M | +72.6% | $42.5M | 7.8% |
| Q1 2025 | $586.0M | +110.7% | $49.5M | 8.4% |
| Q4 2024 | $481.1M | +95.1% | $26.0M | 5.4% |
| Q3 2024 | $401.6M | +77.1% | $75.6M | 18.8% |
| Q2 2024 | $315.6M | +51.8% | $13.3M | 4.2% |
| Q1 2024 | $278.2M | +45.8% | $11.1M | 4.0% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $278.2M | $315.6M | $401.6M | $481.1M | $586.0M | $544.8M | $599.0M | $617.8M |
| YoY Growth | 45.8% | 51.8% | 77.1% | 95.1% | 110.7% | 72.6% | 49.2% | 28.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $448.1M | $480.5M | $602.3M | $707.5M | $891.7M | $1.88B | $2.23B | $2.15B |
| Liabilities | $103.6M | $118.5M | $162.2M | $230.8M | $342.4M | $1.31B | $1.65B | $1.61B |
| Equity | $344.5M | $362.0M | $440.1M | $476.7M | $549.3M | $562.7M | $581.0M | $540.9M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $25.8M | $53.6M | $85.3M | $86.4M | $109.1M | $-19.1M | $148.7M | $61.3M |